Literature DB >> 16275263

Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.

Ernesto Bosch1, Ernesto Escudero, Juana Crespo, Carlos Simón, José Remohí, Antonio Pellicer.   

Abstract

The serum LH was determined on days 3, 6, and 8 of stimulation and on the day of hCG in 110 normogonadotropic patients undergoing controlled ovarian hyperstimulation (COH) for IVF induced with GnRH antagonists and recombinant FSH, creating three groups of patients according to Tukey's hinges (percentiles 25 and 75) for each determination. No differences were observed between the number of oocytes recovered or the fertilization, implantation, and pregnancy rates (PR) of the groups, although patients with high serum LH levels during stimulation showed significantly higher serum E2 levels on the day of hCG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275263     DOI: 10.1016/j.fertnstert.2005.05.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Outcome Analysis of Day-3 Frozen Embryo Transfer v/s Fresh Embryo Transfer in Infertility: A Prospective Therapeutic Study in Indian Scenario.

Authors:  Neha Palo Chandel; Vidya V Bhat; B S Bhat; Sidharth S Chandel
Journal:  J Obstet Gynaecol India       Date:  2015-05-22

2.  The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.

Authors:  J S Younis; I Izhaki; M Ben-Ami
Journal:  J Endocrinol Invest       Date:  2017-03-13       Impact factor: 4.256

3.  Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?

Authors:  Amar Ramachandran; Kshitij Jamdade; Pratap Kumar; Satish Kumar Adiga; Rajeshwari G Bhat; Sinatra R Ferrao
Journal:  J Clin Diagn Res       Date:  2014-01-12

4.  Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.

Authors:  Yiyang Luo; Shan Liu; Hui Su; Lin Hua; Haiying Ren; Minghui Liu; Yuting Wan; Huanhuan Li; Yuan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

5.  Pregnancy confirmed after controlled ovarian stimulation for infertility: A case report.

Authors:  Meiyan Jiang; Chong Wang; Xiaoyang Fei; Zhenyun Lin
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

6.  Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol.

Authors:  Chen Chen; Sha Yu; Weina Yu; Zhiguang Yan; Wei Jin; Jiqiang Si; Menghui Li; Renfei Cai; Dongying Li; Li Wang; Qiuju Chen; Yanping Kuang; Qifeng Lyu; Hui Long
Journal:  Front Physiol       Date:  2022-02-11       Impact factor: 4.566

7.  Luteinizing hormone-based modified GnRH antagonist protocol in normal responders undergoing in vitro fertilization treatment: A multi-center randomized controlled trial.

Authors:  Shan Liu; Yasu Lv; Minghui Liu; Shuo Han; Xiaoqun Liu; Zhiming Zhao; Wei Cui; Aijun Yang; Yuan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

8.  Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.

Authors:  Raffaella Depalo; Paolo Trerotoli; Annarosa Chincoli; Margherita Patrizia Vacca; Giuseppina Lamanna; Ettore Cicinelli
Journal:  Int J Reprod Biomed       Date:  2018-03

9.  Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer.

Authors:  Abdelhamid Benmachiche; Sebti Benbouhedja; Abdelali Zoghmar; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.